| Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation CH Andreasen, KL Stender-Petersen, MS Mogensen, SS Torekov, ... Diabetes 57 (1), 95-101, 2008 | 667 | 2008 |
| Impact of postprandial glycaemia on health and prevention of disease EE Blaak, JM Antoine, D Benton, I Björck, L Bozzetto, F Brouns, ... Obesity reviews 13 (10), 923-984, 2012 | 520 | 2012 |
| GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study K Færch, SS Torekov, D Vistisen, NB Johansen, DR Witte, A Jonsson, ... Diabetes 64 (7), 2513-2525, 2015 | 286 | 2015 |
| An overview of once‐weekly glucagon‐like peptide‐1 receptor agonists—available efficacy and safety data and perspectives for the future S Madsbad, U Kielgast, M Asmar, CF Deacon, SS Torekov, JJ Holst Diabetes, Obesity and Metabolism 13 (5), 394-407, 2011 | 249 | 2011 |
| Healthy weight loss maintenance with exercise, liraglutide, or both combined JR Lundgren, C Janus, SBK Jensen, CR Juhl, LM Olsen, RM Christensen, ... New England Journal of Medicine 384 (18), 1719-1730, 2021 | 220 | 2021 |
| Proteomics reveals the effects of sustained weight loss on the human plasma proteome PE Geyer, NJ Wewer Albrechtsen, S Tyanova, N Grassl, EW Iepsen, ... Molecular systems biology 12 (12), 901, 2016 | 212 | 2016 |
| Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation K Færch, D Vistisen, G Pacini, SS Torekov, NB Johansen, DR Witte, ... Diabetes 65 (11), 3473-3481, 2016 | 188 | 2016 |
| GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women EW Iepsen, JR Lundgren, B Hartmann, O Pedersen, T Hansen, ... The Journal of Clinical Endocrinology & Metabolism 100 (8), 2909-2917, 2015 | 149 | 2015 |
| Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist EW Iepsen, J Zhang, HS Thomsen, EL Hansen, M Hollensted, S Madsbad, ... Cell metabolism 28 (1), 23-32. e3, 2018 | 115 | 2018 |
| Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss EW Iepsen, J Lundgren, C Dirksen, JEB Jensen, O Pedersen, T Hansen, ... International Journal of Obesity 39 (5), 834-841, 2015 | 115 | 2015 |
| Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3–36 EW Iepsen, J Lundgren, JJ Holst, S Madsbad, SS Torekov European journal of endocrinology 174 (6), 775-784, 2016 | 95 | 2016 |
| Plasma proteome profiling reveals dynamics of inflammatory and lipid homeostasis markers after Roux-En-Y gastric bypass surgery NJW Albrechtsen, PE Geyer, S Doll, PV Treit, KN Bojsen-Møller, ... Cell systems 7 (6), 601-612. e3, 2018 | 94 | 2018 |
| A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased … SS Torekov, T Harsløf, L Rejnmark, P Eiken, JB Jensen, AP Herman, ... The Journal of Clinical Endocrinology & Metabolism 99 (4), E729-E733, 2014 | 94 | 2014 |
| Liraglutide for type 2 diabetes and obesity: a 2015 update EW Iepsen, SS Torekov, JJ Holst Expert review of cardiovascular therapy 13 (7), 753-767, 2015 | 93 | 2015 |
| Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids NJ Wewer Albrechtsen, K Færch, TM Jensen, DR Witte, J Pedersen, ... Diabetologia 61, 671-680, 2018 | 87 | 2018 |
| Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis M Winther-Sørensen, KD Galsgaard, A Santos, SAJ Trammell, K Sulek, ... Molecular metabolism 42, 101080, 2020 | 85 | 2020 |
| KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia SS Torekov, E Iepsen, M Christiansen, A Linneberg, O Pedersen, JJ Holst, ... Diabetes 63 (4), 1315-1325, 2014 | 84 | 2014 |
| Obesity–an indication for GLP‐1 treatment? Obesity pathophysiology and GLP‐1 treatment potential SS Torekov, S Madsbad, JJ Holst obesity reviews 12 (8), 593-601, 2011 | 82 | 2011 |
| Association between neuromedin U gene variants and overweight and obesity I Hainerová, SS Torekov, J Ek, M Finková, K Borch-Johnsen, T Jørgensen, ... The Journal of Clinical Endocrinology & Metabolism 91 (12), 5057-5063, 2006 | 76 | 2006 |
| Fat-secreted ceramides regulate vascular redox state and influence outcomes in patients with cardiovascular disease N Akawi, A Checa, AS Antonopoulos, I Akoumianakis, E Daskalaki, ... Journal of the American College of Cardiology 77 (20), 2494-2513, 2021 | 65 | 2021 |
Oluf PedersenProfessor of Metabolic Genetics, University of Copenhagen在 sund.ku.dk 的电子邮件经过验证
